Oragenics, Inc. (OGEN)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biotechnology	37.65K	131.52K	86.99K
Biotechnology Growth	-71.37%	51.20%	-
Total	37.65K	131.52K	86.99K
Total Growth	-71.37%	51.20%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	37.65K	131.52K	86.99K
United States Growth	-71.37%	51.20%	-
Total	37.65K	131.52K	86.99K
Total Growth	-71.37%	51.20%	-

Source: S&P Global Market Intelligence.